|
Click to view this email in browser Forward this message to a friend |
|
 |
|
|
Volume 3, Issue 5, May 2010 www.nutraceuticalmedicalresearch.com |
|
| In this issue: | |
|
NMR NEWS: NMR Gains Footing with New Exhibitors at SupplySide East 2010 INDUSTRY NEWS: |
Recent Clinical Study Shows Consumption of Nuts Beneficial to Heart Health |
|
Receive a free 15-minute consultation when you call us. Call NMR today at 1-914-220-8325 or email us at info@nutraceuticalmedicalresearch.com |
|
|
NMR NEWS |
|
|
NMR Gains Footing with New Exhibitors at SupplySide East 2010 At SupplySide East 2010, held at Meadowlands Expo Center, where droves of attendees flooded the exhibit hall on the first day of the show, three representatives of Nutraceutical Medical Research (NMR) got in on a piece of the action awaiting them. During the two-day exhibit, NMR walked around an over 200 booth-filled hall and introduced themselves and their services to both domestic and international companies, known and new, in all product categories including flavors, finished products, and ingredients. NMR Offers Food and Ingredient Companies Powerful Technical Writing & Clinical Trial Services to Maximize Sales and Differentiate Products Over the years, NMR has developed world-class expertise in proving efficacy and safety using evidence-based approaches, and producing publishable medical literature for the dietary supplement, ingredient, and nutraceutical industries. In 2010, NMR has expanded their reach to include the food and beverage industries. |
|
|
INDUSTRY NEWS |
|
|
Recent Clinical Study Shows Consumption of Nuts Beneficial to Heart Health Data pooled from 25 clinical trials supported the observation that the consumption of nuts is beneficial to heart health. The results of this pooled analysis were reported on May 10, 2010 by Joan Sabate, Keiji Oda, and Emilio Ros. Probiotics for the Control of Clostridium difficile Clostridium difficile is a bacterium that can cause serious infections of the human intestine. Resistant to many commonly used antibiotics, C. difficile is transferred from patient-to-patient by an oral-fecal route. Infection of a susceptible people by C. difficile is on the rise in hospitals, nursing homes, and long-term care facilities. C. difficile gains a foothold in the intestine while patients are treated with antibiotics that kill both pathogenic bacteria and the natural population of harmless bacteria residing in the intestines. Preliminary clinical trials indicate probiotics may prevent C. difficile infections in hospitals and similar settings. However, additional clinical trials are required in order to establish treatment protocols. |
|
|
NMR will be attending the following event(s):
Chicago, IL July 17 - 20, 2010 |
|
|
Have a well-written, reader-friendly published piece in hand to showcase your ingredient/product in less than 3 weeks. Call NMR at 1-914-220-8325 or email info@nutraceuticalmedicalresearch.com for a custom quote! |
|
|
Connect with NMR on Facebook & LinkedIn
|
Nutraceutical Medical Research, LLC | 445 Hamilton Avenue | Suite 1102 | White Plains, New York | 10601 Tel: 1-914-220-8325 | Fax: 1-914-220-8329 W: www.nutraceuticalmedicalresearch.com | E: info@nutraceuticalmedicalresearch.com Subscribe to free monthly e-newsletters here |
| © Copyright 2010 Nutraceutical Medical Research, LLC - All Rights Reserved. | |
|
Click to view this email in a browser
If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe |
|
Nutraceutical Medical Research 445 Hamilton Avenue Suite 1102 White Plains, New York 10601
|
Do you need a clinical trial designed and implemented quickly?
Engage and reach your audience with powerful literature on your ingredient or finished product.jpg "Facebook icon (small).jpg")
